Annual EBIT
-$41.88 M
-$23.46 M-127.43%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual earnings before interest & taxes is -$41.88 million, with the most recent change of -$23.46 million (-127.43%) on December 31, 2023.
- During the last 3 years, SABS annual EBIT has fallen by -$62.47 million (-303.42%).
- SABS annual EBIT is now -303.42% below its all-time high of $20.59 million, reached on December 31, 2020.
Performance
SABS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$10.27 M
-$3.03 M-41.83%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly earnings before interest & taxes is -$10.27 million, with the most recent change of -$3.03 million (-41.83%) on September 30, 2024.
- Over the past year, SABS quarterly EBIT has dropped by -$5.24 million (-104.10%).
- SABS quarterly EBIT is now -791.68% below its all-time high of $1.49 million, reached on March 31, 2021.
Performance
SABS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$45.24 M
-$5.24 M-13.10%
September 30, 2024
Summary
- As of February 8, 2025, SABS TTM earnings before interest & taxes is -$45.24 million, with the most recent change of -$5.24 million (-13.10%) on September 30, 2024.
- Over the past year, SABS TTM EBIT has dropped by -$18.38 million (-68.43%).
- SABS TTM EBIT is now -3146.60% below its all-time high of $1.49 million, reached on March 31, 2021.
Performance
SABS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SABS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -127.4% | -104.1% | -68.4% |
| 3 y3 years | -303.4% | -46.6% | -104.4% |
| 5 y5 years | -389.4% | -46.6% | -104.4% |
SABS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -148.5% | at low | -993.0% | +54.9% | -168.5% | at low |
| 5 y | 5-year | -303.4% | at low | -791.7% | +54.9% | -3146.6% | at low |
| alltime | all time | -303.4% | at low | -791.7% | +54.9% | -3146.6% | at low |
SAB Biotherapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$10.27 M(+41.8%) | -$45.24 M(+13.1%) |
| Jun 2024 | - | -$7.24 M(+46.3%) | -$40.00 M(+1.1%) |
| Mar 2024 | - | -$4.95 M(-78.3%) | -$39.57 M(-5.5%) |
| Dec 2023 | -$41.88 M(+127.4%) | -$22.78 M(+352.6%) | -$41.88 M(+55.9%) |
| Sep 2023 | - | -$5.03 M(-26.1%) | -$26.86 M(-6.8%) |
| Jun 2023 | - | -$6.81 M(-6.3%) | -$28.83 M(+7.5%) |
| Mar 2023 | - | -$7.26 M(-6.4%) | -$26.83 M(+45.7%) |
| Dec 2022 | -$18.41 M | -$7.76 M(+10.8%) | -$18.41 M(-16.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$7.01 M(+46.0%) | -$22.14 M(+15.8%) |
| Jun 2022 | - | -$4.80 M(-517.1%) | -$19.11 M(+11.2%) |
| Mar 2022 | - | $1.15 M(-110.0%) | -$17.18 M(+2.0%) |
| Dec 2021 | -$16.85 M(-181.8%) | -$11.49 M(+188.4%) | -$16.85 M(+214.1%) |
| Sep 2021 | - | -$3.98 M(+38.9%) | -$5.36 M(+288.1%) |
| Jun 2021 | - | -$2.87 M(-293.1%) | -$1.38 M(-193.1%) |
| Mar 2021 | - | $1.49 M | $1.49 M |
| Dec 2020 | $20.59 M(-340.6%) | - | - |
| Dec 2019 | -$8.56 M | - | - |
FAQ
- What is SAB Biotherapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual EBIT year-on-year change?
- What is SAB Biotherapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly EBIT year-on-year change?
- What is SAB Biotherapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for SAB Biotherapeutics?
- What is SAB Biotherapeutics TTM EBIT year-on-year change?
What is SAB Biotherapeutics annual earnings before interest & taxes?
The current annual EBIT of SABS is -$41.88 M
What is the all time high annual EBIT for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual earnings before interest & taxes is $20.59 M
What is SAB Biotherapeutics annual EBIT year-on-year change?
Over the past year, SABS annual earnings before interest & taxes has changed by -$23.46 M (-127.43%)
What is SAB Biotherapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of SABS is -$10.27 M
What is the all time high quarterly EBIT for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly earnings before interest & taxes is $1.49 M
What is SAB Biotherapeutics quarterly EBIT year-on-year change?
Over the past year, SABS quarterly earnings before interest & taxes has changed by -$5.24 M (-104.10%)
What is SAB Biotherapeutics TTM earnings before interest & taxes?
The current TTM EBIT of SABS is -$45.24 M
What is the all time high TTM EBIT for SAB Biotherapeutics?
SAB Biotherapeutics all-time high TTM earnings before interest & taxes is $1.49 M
What is SAB Biotherapeutics TTM EBIT year-on-year change?
Over the past year, SABS TTM earnings before interest & taxes has changed by -$18.38 M (-68.43%)